好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Press Release

EMBARGOED FOR RELEASE UNTIL 4 PM ET, June 05, 2019

Brain Changes May Be Linked to Unexplained Motor Symptoms

MINNEAPOLIS -

A new study finds that people who have movement problems, symptoms that cannot be explained by an underlying disease, may have chemical changes in specific areas of the brain. The study is published in the June 5, 2019, online issue of , the medical journal of the . These symptoms, which include tremors, muscle contractions or problems with walking, are called functional or psychogenic motor symptoms. 鈥淭hese results bring new perspectives to the problem of functional motor symptoms, which have mainly been considered psychological problems,鈥 said study author Alberto Priori, MD, PhD, of the 鈥淎ldo Ravelli鈥 Research Center at the University of Milan in Italy. 鈥淭hese findings suggest that these abnormal chemical changes in the brain could play a key role in functional motor symptoms, ultimately leading to the abnormal movements.鈥 Priori said that drugs could potentially be developed that could target these chemical changes in the brain to help treat functional motor symptoms. The study compared 10 people with functional motor symptoms to 10 people with no health problems. Researchers used a brain scan called magnetic resonance spectroscopy to look at biochemical processes within the brain. Participants also took tests for depression, anxiety, quality of life and a condition called alexithymia, which is a failure to identify and describe emotions in oneself. The people with functional motor symptoms had increased levels of glutamate and glutamine in the limbic areas of the brain, with levels approximately four times higher than in the healthy people. Glutamate and glutamine were however normal outside the limbic areas, thus demonstrating that the finding is specific for these regions. On the psychological tests, the people with functional motor symptoms had abnormal scores while the people without symptoms had normal scores. Two of the people with symptoms had major depression disorder and one had panic disorder. The people with symptoms had high scores in depression, anxiety, alexithymia and low scores for quality of life. For example, those with symptoms had an average score of 9.0 on the depression test, which indicates mild depression, compared to an average score of 1.4 for those with no symptoms, which indicates no depression. The researchers also found that higher neurochemical abnormalities in the brain were associated with more severe motor, anxiety and alexithymia symptoms. 鈥淏ecause the abnormal increase in glutamate and glutamine may play a role in functional motor symptoms, drugs modulating glutamatergic activity, such as D-cycloserine, memantine or ketamine, could potentially offer a strategy to help manage these disabling disorders,鈥 Priori said. The main limitation of the study is the small number of participants. The study was partly supported in part by the 鈥淎ldo Ravelli鈥 Research Center on Neurotechnology and Experimental Brain Therapeutics at the University of Milan in Italy. Learn more about the brain health at , home of the 好色先生鈥檚 free patient and caregiver magazine focused on the intersection of neurologic disease and brain health. Follow Brain & Life on , and .

Brain & Life logo

GET A DOSE OF BRAIN HEALTH

Dive into a wealth of information by visiting Brain & Life庐, where you can explore the freshest updates, tips, and neurologist expert perspectives on brain disease and preventive brain health.


The 好色先生 is the leading voice in brain health. As the world鈥檚 largest association of neurologists and neuroscience professionals with more than 40,000 members, the AAN provides access to the latest news, science and research affecting neurology for patients, caregivers, physicians and professionals alike. The AAN鈥檚 mission is to enhance member career fulfillment and promote brain health for all. A neurologist is a doctor who specializes in the diagnosis, care and treatment of brain, spinal cord and nervous system diseases such as Alzheimer's disease, stroke, concussion, epilepsy, Parkinson's disease, multiple sclerosis, headache and migraine.

Explore the latest in neurological disease and brain health, from the minds at the AAN at or find us on , , , and .

For More Information*

Email media@aan.com

*While content of the 好色先生 (AAN) press releases is developed by the AAN along with research authors and Neurology® editors, we are unable to provide medical advice to individuals. Please contact your health care provider for questions specific to your individual health history or care. For more resources, visit the AAN's patient and caregiver magazine website, .